Part II: Transferring Data Safely: National Security, Privacy, and Emerging Sovereign Rights

Cross-border data flows in the life sciences sector sit at the crossroads of national security enforcement, evolving privacy law, and a new generation of sovereign data rights claims — creating compliance complexity that few organizations are fully prepared for. Featuring former national security officials, a privacy law specialist, and an intellectual property lawyer with extensive emerging technology experience, this session translates a rapidly shifting legal landscape into actionable insight. Whether your concern is clinical trial data, genomic and biomarker research, drug compound formulas, APIs, or joint ventures with foreign partners — together, this panel will offer practical guidance for companies navigating this rapidly evolving and high-consequence landscape.

We invite you to join us and to come with questions!

Save the Date

Information and details to follow